Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
Transnet N1 Culemborg Eviction
By Brendan Olivier, Director and Kristen Elliott, Senior Associate The Western Cape High Court has ordered the eviction of over [...]
A brief overview of the Small Claims Court (2026 update)
by Dakalo Singo, Director and Head of Pro Bono What is the Small Claims Court? The Small Claims Court ("SCC") [...]
Success of the South African Business Rescue Process – Positive news for the restructuring of distressed companies
by Dr. Eric Levenstein, Director and Head of Insolvency & Business Rescue Dr Eric Levenstein unpacks the legal significance of recent [...]
South Africa’s private equity market finally has a liquidity market: The growing market for secondaries
by Dylan Cunard, Director 1. Introduction 1.1. For much of the past two decades, the conversation in South Africa’s private [...]
Will secondaries solve liquidity issues in South Africa’s private equity market?
by Dylan Cunard, Director A multi-billion dollar revolution in global private capital could arrive in South Africa. South Africa’s private [...]
Procedural certainty in business rescue: Competing commencement processes
by Eric Levenstein, Director and Head of Insolvency & Business Rescue, Brandon Starr, Senior Associate and Clio Patricios, Candidate Attorney [...]
